Nanosphere announces FDA submission of 510k for its troponin I test
Nanosphere announced it submitted a 510(k) application to the FDA for its cardiac troponin I test that the company believes will provide early and sensitive diagnosis of myocardial infarction and risk stratification for acute coronary syndromes. :theflyonthewall.com
News For NSPH From The Last 14 Days
Check below for free stories on NSPH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
